One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor: A Randomized Trial

Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Jörg T. Hartmann, Daniel Pink, Jochen Schütte, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo-Rikala, Bengt Nilsson, Harri Sihto, Odd R. Monge, Petri Bono, Raija Kallio, Aki VehtariMika Leinonen, Thor Alvegård, Peter Reichardt

Research output: Contribution to journalArticleScientificpeer-review

587 Citations (Scopus)
Original languageEnglish
Pages (from-to)1265-1272
JournalJAMA : JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume307
Issue number12
Publication statusPublished - 2012
MoE publication typeA1 Journal article-refereed

Cite this